SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Ruck Andreas)
 

Search: WFRF:(Ruck Andreas) > Hemodynamic outcome...

Hemodynamic outcomes of transcatheter aortic valve implantation with the CoreValve system : an early assessment

da Silva, Cristina (author)
KTH,Medicinsk bildteknik,Karolinska Institute, Stockholm, Sweden
Sahlén, Anders (author)
Winter, Reidar (author)
KTH,Medicinsk bildteknik,Karolinska University Hospital, Sweden
show more...
Bäck, Magnus (author)
Karolinska Institutet
Ruck, Andreas (author)
Karolinska Institutet
Settergren, Magnus (author)
Karolinska Institutet
Manouras, Aristomenis (author)
Karolinska Institutet,KTH,Medicinsk bildteknik,Department of Cardiology, Karolinska University Hospital, Huddinge, Sweden
Shahgaldi, Kambiz (author)
KTH,Medicinsk bildteknik,Department of Cardiology, Karolinska University Hospital, Huddinge, Sweden
show less...
 (creator_code:org_t)
2014-04-22
2015
English.
In: Clinical Physiology and Functional Imaging. - : Wiley. - 1475-0961 .- 1475-097X. ; 35:3, s. 216-222
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background and Aims: Transcatheter aortic valve implantation (TAVI) is an established method for the treatment of high-risk patients with aortic stenosis (AS). The beneficial effects of TAVI in cardiac hemodynamics have been described in recent studies, but those investigations were mostly performed after an interval of more than 6 months following aortic valve implantation. The aim of this study is to investigate the acute and short-term alterations in hemodynamic conditions using the echocardiography outcomes in patients undergoing TAVI. Methods and Results: A total of 60 patients (26 males, 34 females; age 84·7 ± 5·8) who underwent TAVI with CoreValve system were included in the study. Echocardiography was performed before hospital discharge and at 3 months follow-up. As expected, TAVI was associated with an immediate significant improvement in aortic valve area (AVA) (from 0·64 ± 0·16 cm2 to 1·67 ± 0·41 cm2, P-value<0·001) and mean gradient (from 51·9 ± 15·4 mmHg to 8·8 ± 3·8 mmHg, P-value<0·001). At 3-month follow-up, systolic LV function was augmented (EF: 50 ± 14% to 54 ± 11%, P-value = 0·024). Left ventricle (LV) mass and left atrium (LA) volume were significantly reduced (LV mass index from 126·5 ± 30·5 g m-2 to 102·4 ± 32·4 g m-2; LA index from 42·9 ± 17·3 ml m-2 to 33·6 ± 10·6 ml m-2; P-value<0·001 for both). Furthermore, a decrement in systolic pulmonary artery pressure (SPAP) from 47·5 ± 13·5 mmHg to 42·5 ± 11·2 mmHg, P-value = 0·02 was also observed. Despite the high incidence of paravalvular regurgitation (PVR) (80%), most of the patients presented mild or trace PVR and no significant progress of the regurgitation grade was seen after 3 months. Conclusion: This study demonstrates that the beneficial effects of TAVI in cardiac function and hemodynamics occur already after a short period following aortic valve implantation.

Subject headings

TEKNIK OCH TEKNOLOGIER  -- Medicinteknik (hsv//swe)
ENGINEERING AND TECHNOLOGY  -- Medical Engineering (hsv//eng)

Keyword

aortic stenosis
CoreValve
echocardiography

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view